Join the club for FREE to access the whole archive and other member benefits.

Bionaut labs developed microbots to tackle untreatable cancers

Real injectable robots delivering drugs exactly where they're needed - the future is here!

03-Mar-2021

Key points from article :

Bionaut Labs is raising the curtain on its tiny, remote-controlled devices.

Smaller than a millimeter and with a few moving parts.

Guided only by magnetic fields generated outside the body.

To overcome the obvious constraint that holds back surgical drills, probes and needles.

To start, the company aims to tackle gliomas of the brainstem.

Safely navigate to the cancer and unlock a mechanism that delivers chemotherapies directly.

“Higher drug concentrations in situ, much lower to nonexistent concentrations in the plasma," - Michael Shpigelmacher, CEO of Bionaut Labs.

Preclinical studies on small and large live animals, showing no long-term neurological damage.

Raised $20 million to help take it to the next step and moving into human clinical trials planned for 2023.

“Therapeutic potential extends to many diseases where conventional therapies are limited or lacking," - Vinod Khosla, founder of Khosla Ventures.

Mentioned in this article:

Click on resource name for more details.

Bionaut Labs

A biotech startup that designs and manufactures intra- tissue navigation platform

Michael Shpigelmacher

Co-founder, CEO at Bionaut Labs

Vinod Khosla

Partner at Khosla Ventures

Topics mentioned on this page:
Nanobots, Cancer